1. Home
  2. IRTC vs KRYS Comparison

IRTC vs KRYS Comparison

Compare IRTC & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

HOLD

Current Price

$128.06

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$265.29

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRTC
KRYS
Founded
2006
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
7.8B
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
IRTC
KRYS
Price
$128.06
$265.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
10
Target Price
$209.69
$297.60
AVG Volume (30 Days)
646.5K
267.5K
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
61.71
128.00
EPS
N/A
6.84
Revenue
$747,138,000.00
$389,130,000.00
Revenue This Year
$18.26
$44.50
Revenue Next Year
$15.44
$34.79
P/E Ratio
N/A
$38.70
Revenue Growth
26.24
33.94
52 Week Low
$92.52
$123.03
52 Week High
$210.01
$298.30

Technical Indicators

Market Signals
Indicator
IRTC
KRYS
Relative Strength Index (RSI) 33.57 47.61
Support Level N/A $255.65
Resistance Level $158.52 $293.60
Average True Range (ATR) 8.43 12.28
MACD -1.52 -1.64
Stochastic Oscillator 18.56 29.10

Price Performance

Historical Comparison
IRTC
KRYS

About IRTC iRhythm Technologies Inc.

iRhythm Holdings Inc formerly, iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: